Feasibility of single-dose neoadjuvant pembrolizumab with subablative radiotherapy in operable breast cancer: a single-centre phase 1b/2 window-of-opportunity trial

eBioMedicine · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles